Skip to main content
Log in

Stimulation of proliferative activity of human natural killers (CD16+CD56+ cells) by recombinant interleukin-3in vitro

  • Microbiology and Immunology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The proliferative activity of human natural killers (CD16+CD56+ cells) in the presence of 100 and 1000 IU/ml human recombinant interleukin-3 is investigatedin vitro. It is shown that recombinant interleukin-3 reliably enhances natural killer proliferation, causing a 9–15.2-fold increase of3H-thymidine uptake by CD16+CD56+ cells both in complete culture medium and in conditioned medium. The effect of the factor is 3.9–6.4 and 3.6–8.9-fold more potent than that of recombinant interleukin-2 and granulocyte-macrophage colony-stimulating factor, respectively, in the same doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A. N. Cheredeev and L. V. Koval'chuk,Advances in Science and Technology, Series Immunology, [in Russian], Vol. 19, Moscow (1989), pp. 3–237.

  2. A. A. Yarilin,Immunologiya, No. 4, 5–14 (1987).

    Google Scholar 

  3. M.-H. B. Aribia, E. Leroy, O. Lantz,et al., J. Immunol.,139, No. 2, 443–451 (1987).

    PubMed  CAS  Google Scholar 

  4. E. Braakman, A. van Tunen, A. Meager, and C. J. Lucas,Cell Immunol.,99, 476–488 (1986).

    Article  PubMed  CAS  Google Scholar 

  5. Li Hao, R. Schwinzer, M. Baccarini and M.-L. Lohmann-Matthes,J. Exp. Med.,169, No. 3, 973–986 (1989).

    Article  Google Scholar 

  6. C. S. Henney, K. Kuribayashi, D. E. Kern, and S. Gillis,Nature,291, 335–337 (1981).

    Article  PubMed  CAS  Google Scholar 

  7. T. Hercend and R. E. Schmidt,Immunol. Today,9, No. 10, 291–293 (1988).

    Article  PubMed  CAS  Google Scholar 

  8. T. Kalland,J. Immunol.,137, No. 7, 2268–2271 (1986).

    PubMed  CAS  Google Scholar 

  9. C. A. Keever, K. Pekle, M. V. Gazzola,et al.,,143, No. 10, 3241–3249 (1989).

    PubMed  CAS  Google Scholar 

  10. L. L. Lanier, H. Spits, and J. H. Phillips,Immunol. Today,13, No. 10, 392–395 (1992).

    Article  PubMed  CAS  Google Scholar 

  11. G. Migliorati, L. Cannarile, and R. B. Herberman,J. Immunol.,138, No. 11, 3618–3625 (1987).

    PubMed  CAS  Google Scholar 

  12. T. A. Moore, M. Bennett, and V. Kumar,Nat. Immun. Cell. Growth Regul.,10, No. 3, 157–158 (1991).

    Google Scholar 

  13. J. E. Talmadge, R. H. Wiltrout, D. F. Counts,et al., Cell. Immunol.,102, 261–272 (1986).

    Article  PubMed  CAS  Google Scholar 

  14. H. S. Warren,J. Leukocyte Biol., Suppl., 105 (1993).

  15. H. S. Warren, B. F. Kinnear, and L. J. Skipsey,Immunol. Cell Biol.,73, No. 2, 87–97 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 119, No 4, pp. 409–412, April, 1995

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheknev, S.B. Stimulation of proliferative activity of human natural killers (CD16+CD56+ cells) by recombinant interleukin-3in vitro . Bull Exp Biol Med 119, 396–399 (1995). https://doi.org/10.1007/BF02445903

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02445903

Key Words

Navigation